UCTV Seminars

description:

Drug therapy has led to dramatic advances in the treatment of many diseases, but many unmet needs remain, in areas such as in cancer, cardiovascular disease, Alzheimer's and Parkinson's. In addition, the need for new antimicrobials is pressing, due to the threat of drug-resistant pathogens, coupled with the emergence of new infectious diseases and a lack of adequate treatments for many diseases of the developing world. Fundamental and applied research advances are generating opportunities for new therapies in these and other disease areas, but the productivity of the pharma and biotech industries is lagging. Today, both industry and government look increasingly to academia as a primary source of innovation to accelerate the creation of new medications.